FDA Adverse Event Injury Summary report: N

INFINION CX

MDR report key: 11277881 · Received February 4, 2021

Report

Report Number
3006630150-2021-00266
Event Type
Injury
Date Received
February 4, 2021
Date of Event
December 27, 2020
Report Date
February 4, 2021
Manufacturer
BOSTON SCIENTIFIC NEUROMODULATION
Product Code
LGW
UDI-DI
08714729861614
PMA / PMN Number
P030017
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
ID, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

APPROXIMATED BASED ON THE DATE THE MANUFACTURER BECAME AWARE OF THE EVENT. ADDITIONAL SUSPECT MEDICAL DEVICE COMPONENT INVOLVED IN THE EVENT: PRODUCT FAMILY: SCS-LINEAR LEADS UPN: M365SC2317500 MODEL: SC-2317-50 SERIAL:(B)(4). BATCH: 7031371.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE LEFT LEAD DEVELOPED A SIGNIFICANT SCAR TISSUE ENOUGH FOR PATIENT TO EXPERIENCED INADEQUATE STIMULATION. THE PATIENT UNDERWENT A LEAD REPLACEMENT PROCEDURE AND WAS DOING WELL POSTOPERATIVELY. THE EXPLANTED LEAD WAS DISCARDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
174754 INFINION CX STIMULATOR, SPINAL-CORD, TOTALLY IMPLANTED FOR PAIN RELIEF LGW BOSTON SCIENTIFIC NEUROMODULATION SC-2317-50 5134517 08714729861614

Patients

Seq Age Sex Outcome Treatment
1 70 YR Required Intervention